GW Pharmaceuticals Plc - American Depositary Shares


Updates from The Motley Fool

Latest updates on GW Pharmaceuticals from Fool.com.  The Fool has written over 200 articles on GW Pharmaceuticals.
GW Pharmaceuticals in 5 Charts

GW Pharmaceuticals (NASDAQ: GWPH) has come a long ways since gaining EU approval for Sativex, wh...

3 Stocks That Are Overvalued

Every stock has a fair price. Pay too much, and you might get burned. Image source: Getty Images....



Stock Performance

View Interactive GWPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about GW Pharmaceuticals.
Current Price: $115.06
Prev Close: $118.19
Open: $119.48
Bid: $115.00
Ask: $116.10
Day's Range: $114.18 - $120.30
52wk Range: $35.83 - $137.88
Volume: 539,753
Avg Vol 619,341
Market Cap: $3B
P/E (ttm): -393.97
EPS (ttm): ($0.30)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about GW Pharmaceuticals.
CAPS Rating 2 out of 5
 
141 Outperform
22 Underperform
CAPS All Stars
 
20 Outperform
13 Underperform

How do you think GW Pharmaceuticals will perform against the market?



You pick for GW Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Justin Gover, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for GW Pharmaceuticals.

GW Pharmaceuticals Plc - American Depositary Shares

  • Exchange: NASDAQ